Research & Development
Pathology & AI
Artificial Intelligence: Page 2
AI-based diagnostics firm Ibex Medical Analytics secures $10M in financing
Funding will also be used to accelerate research and development initiatives that focus on adding new applications to the company’s Galen platform.
November 9, 2022
Mayo Clinic, Numares Health expand collaboration, develop AI-enabled diagnostic testing for chronic disease
Expanding upon Mayo Clinic’s clinical research support for Numares Health, the collaboration will focus on researching and developing AI-enabled diagnostic testing solutions.
November 3, 2022
Proscia retrospective study describes potential of AI in diagnosing melanoma, other diseases
Proscia presented the results at the European Conference on Computer Vision 2022, showing how AI performed in the diagnosis of melanoma using whole-slide images.
November 1, 2022
Deepcell expands adoption of AI-enabled morphology characterization for biological researchers
The University of California, San Francisco and the Translational Genomics Research Institute are the initial locations to have the first generation of the Deepcell platform installed through a Technology Access Program.
November 1, 2022
HTG to collaborate with OmiCure on transcriptomic data
Samples collected by OmiCure will be sent to HTG’s lab in Tucson, AZ, where HTP will be used for transcriptome-wide DNA and RNA profiling.
October 26, 2022
NanoString, Visiopharm collaborate on spatial imaging, machine learning for biomarker and drug target discovery
By leveraging their respective technologies, the companies aim to accelerate the discovery of biomarkers and drug targets, as well as enhance and validate high-plex spatial molecular data.
October 13, 2022
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
Simple blood test can detect PTSD biomarkers
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Illumina NGS software to enable tertiary analysis for oncology, rare disease
Serum protein in study predicted which patients might die without a liver transplant
AmoyDx PLC Panel gets Japanese approval as companion diagnostic for NSCLC
GTC reports on validation of targeted transcriptome algorithms for diagnostic use
GTC’s RNAnalysis algorithm is used to distinguish between 45 different diagnostic classes, providing probability scores. The algorithm is complemented by a second one called TraceWork.
October 13, 2022
Proscia launches expanded digital pathology platform for primary diagnostic workflows
The product brings together new features to help laboratory networks transition to 100% digital diagnosis and shift away from microscope-based pathology, the firm said.
October 12, 2022
Immucor, Pirche partner on expanding transplantation diagnostics software
The firms have announced a multiyear partnership aimed at expanding Immucor's transplant compatibility diagnostics software.
October 4, 2022
U.K. study: Blood test may predict long-COVID risk
A U.K. study led by researchers at University College London (UCL) shows that a blood test performed during the initial infection period may predict who is most likely to develop long COVID.
September 29, 2022
Bionano to use OptraHealth's AI platform for genetic counseling
"We have chosen to incorporate the HealthFax platform into the Bionano Laboratories workflow with the intent to increase operational efficiencies while also improving the overall experience for our clients," Erik Holmlin, president and CEO of Bionano Laboratories' parent company, Bionano Genomics, said in a statement. "With the implementation of these new tools, Bionano Laboratories will be able to scale as it expands services in the future."
September 25, 2022
Leuko nabs $5M for validation of WBC monitoring technology
HTH VC, Good Growth Capital, IAG Capital Partners, Nina Capital, and angel investors provided the funding, Leuko said. The funding will allow the company to accelerate clinical trials with the aim of obtaining regulatory approval in collaboration with leading cancer centers, including the MD Anderson Cancer Center and Boston Medical Center in the U.S., and Dexeus and Hospital 12 de Octubre in Spain.
September 22, 2022
Page 2 of 13